Skip to main content
Erschienen in: Archives of Osteoporosis 1/2018

01.12.2018 | Original Article

FRAX® based intervention thresholds for management of osteoporosis in Singaporean women

verfasst von: M. Chandran, E. V. McCloskey, W. P. P. Thu, S. Logan, Y. Hao, D. Tay, W. C. Ang, T. K. K. Aung, K. S. Choo, A. Ali, S. X. Yan, X. F. Huang, X. M. Liu, E. L. Yong, S. Lekamwasam

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Summary

Potential FRAX®-based major osteoporotic fracture (MOF) and hip fracture (HF) intervention thresholds (ITs) for postmenopausal Singaporean women were explored. Age-dependent ethnic-specific and weighted mean ITs progressively increased with increasing age. Fixed ITs were derived via discriminatory value analysis. MOF and HF ITs with highest the Youden index were chosen as optimal.

Introduction

We aimed to explore FRAX®-based intervention thresholds (ITs) to potentially guide osteoporosis treatment in Singapore, a multi-ethnic nation.

Method

One thousand and one Singaporean postmenopausal community-dwelling women belonging to Chinese, Malay and Indian ethnicities underwent clinical risk factor (CRF) and BMD assessment. FRAX® major osteoporotic fracture (MOF) and hip fracture (HF) probabilities were calculated using ethnic-specific models. We employed the translational logic adopted by NOGG (UK), whereby osteoporosis treatment is recommended to any postmenopausal woman whose fracture probability based on other CRFs is similar to or exceeds that of an age-matched woman with a fracture. Using the same logic, ethnic-specific and mean weighted age-dependent ITs were computed. Employing these age-dependent ITs as a reference, the performance of fixed (age-independent) ITs were examined using ROC curves and discriminatory analysis, with the highest Youden index (YI) (sensitivity + specificity − 1) used to identify the optimal MOF and HF ITs.

Results

The mean age was 58.9 (6.9) years. Seven hundred and eighty-nine (79%) women were Chinese, 136 (13.5%) Indian and 76 (7.5%) Malay. Age-dependent MOF ITs ranged from 3.1 to 33%, 2.5 to 17% and 2.5 to 16% whilst HF ITs ranged from 0.7 to 17%, 0.4 to 6% and 0.4 to 6.3% in Chinese, Malay and Indian women, respectively, between the ages of 50 and 90 years. The weighted age-dependent MOF and HF ITs ranged from 2.9% and 0.6%, respectively, at the age of 50, to 28% and 14% at 90 years of age. Fixed MOF/HF ITs of 5.5%/1%, 2.5%/1% and 2.5%/0.25% were identified as the most optimal by the highest YI in Chinese, Malay and Indian women, respectively. Fixed MOFP and HF ITs of 4% and 1%, respectively, were found to be most optimal on the weighted means analysis.

Conclusion

The ITs for osteoporosis treatment in Singapore show marked variations across ethnicities. Weighted mean thresholds may overcome the dilemma of intervening at different thresholds for different ethnicities. Choosing fixed ITs may have to involve trade-offs between sensitivity and specificity. FRAX®-based age-dependent or the fixed intervention thresholds suggested as an alternative to be considered for use in Singapore though further studies on the societal and health economic impacts of choosing these thresholds in Singapore are needed.
Literatur
1.
Zurück zum Zitat Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994) Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994) Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
4.
Zurück zum Zitat Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43CrossRefPubMedPubMedCentral Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the Diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract 22(Suppl 4):1–42. https://doi.org/10.4158/EP161435.GL CrossRefPubMed Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the Diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract 22(Suppl 4):1–42. https://​doi.​org/​10.​4158/​EP161435.​GL CrossRefPubMed
10.
Zurück zum Zitat McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A et al (2012) Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. J Bone Miner Res 27(7):1480–1486. https://doi.org/10.1002/jbmr.1606 CrossRefPubMed McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A et al (2012) Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. J Bone Miner Res 27(7):1480–1486. https://​doi.​org/​10.​1002/​jbmr.​1606 CrossRefPubMed
17.
Zurück zum Zitat Lekamwasam S (2013) Sri Lankan FRAX model and country-specific intervention thresholds. Arch Osteoporos 8:148CrossRefPubMed Lekamwasam S (2013) Sri Lankan FRAX model and country-specific intervention thresholds. Arch Osteoporos 8:148CrossRefPubMed
19.
Zurück zum Zitat Korthoewer D, Chandran M, Endocrine and Metabolic Society of Singapore (2012) Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific. Arch Osteoporos 7(1–2):193–200CrossRefPubMed Korthoewer D, Chandran M, Endocrine and Metabolic Society of Singapore (2012) Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific. Arch Osteoporos 7(1–2):193–200CrossRefPubMed
21.
Zurück zum Zitat Leong KH, Feng PH (1997) Bone mineral density measurements using the Hologic QD2000 in 175 Singaporean women aged 20–80. Singap Med J 38(1):25–26 Leong KH, Feng PH (1997) Bone mineral density measurements using the Hologic QD2000 in 175 Singaporean women aged 20–80. Singap Med J 38(1):25–26
25.
Zurück zum Zitat McCloskey E, Kanis JA, Johansson H, Harvey N, Odén A, Cooper A, Cooper C, Francis RM, Reid DM, Marsh D, Selby P, Thompson F, Hewitt S, Compston J (2015) FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 26(8):2091–2099. https://doi.org/10.1007/s00198-015-3176-0 CrossRefPubMed McCloskey E, Kanis JA, Johansson H, Harvey N, Odén A, Cooper A, Cooper C, Francis RM, Reid DM, Marsh D, Selby P, Thompson F, Hewitt S, Compston J (2015) FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 26(8):2091–2099. https://​doi.​org/​10.​1007/​s00198-015-3176-0 CrossRefPubMed
29.
Zurück zum Zitat Levis S, Theodore G (2012) Summary of AHRQ’s comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. J Manag Care Pharm 18(4 Suppl B):S1–S15 discussion S13PubMed Levis S, Theodore G (2012) Summary of AHRQ’s comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. J Manag Care Pharm 18(4 Suppl B):S1–S15 discussion S13PubMed
30.
Zurück zum Zitat Ensrud KE, Taylor BC, Peters KW, Gourlay ML, Donaldson MG, Leslie WD et al (2014) Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study. BMJ 349:g4120CrossRefPubMedPubMedCentral Ensrud KE, Taylor BC, Peters KW, Gourlay ML, Donaldson MG, Leslie WD et al (2014) Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study. BMJ 349:g4120CrossRefPubMedPubMedCentral
Metadaten
Titel
FRAX® based intervention thresholds for management of osteoporosis in Singaporean women
verfasst von
M. Chandran
E. V. McCloskey
W. P. P. Thu
S. Logan
Y. Hao
D. Tay
W. C. Ang
T. K. K. Aung
K. S. Choo
A. Ali
S. X. Yan
X. F. Huang
X. M. Liu
E. L. Yong
S. Lekamwasam
Publikationsdatum
01.12.2018
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2018
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-018-0542-5

Weitere Artikel der Ausgabe 1/2018

Archives of Osteoporosis 1/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.